The HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells.
Schütt, M
The HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells. [electronic resource] - Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association Feb 2003 - 16-20 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0947-7349
10.1055/s-2003-37495 doi
Carcinoma, Hepatocellular--enzymology
Glucose--metabolism
Glycogen--biosynthesis
HIV Protease Inhibitors--pharmacology
Humans
Hypoglycemic Agents--pharmacology
Indinavir--pharmacology
Insulin--pharmacology
Liver--drug effects
Liver Neoplasms--enzymology
Protein Tyrosine Phosphatases--metabolism
Stimulation, Chemical
Tumor Cells, Cultured
The HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells. [electronic resource] - Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association Feb 2003 - 16-20 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0947-7349
10.1055/s-2003-37495 doi
Carcinoma, Hepatocellular--enzymology
Glucose--metabolism
Glycogen--biosynthesis
HIV Protease Inhibitors--pharmacology
Humans
Hypoglycemic Agents--pharmacology
Indinavir--pharmacology
Insulin--pharmacology
Liver--drug effects
Liver Neoplasms--enzymology
Protein Tyrosine Phosphatases--metabolism
Stimulation, Chemical
Tumor Cells, Cultured